A Direct Head-to-head Comparison of Ustekinumab With Infliximab for the Treatment of Ulcerative Colitis (clinicaltrials.gov) - Sep 18, 2026 - P=N/A | N=100 | Active, not recruiting | Sponsor: Helwan University | Not yet recruiting ➔ Active, not recruiting | Trial completion date: Oct 2026 ➔ Dec 2027 | Trial primary completion date: Jun 2026 ➔ Dec 2027
Enrollment closed • Head-to-Head • Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
|